Jaye Gardiner, a postdoctoral researcher at Fox Chase Cancer Center, has received the inaugural Black in Cancer postdoctoral fellowship, which will provide $75,000 annually for three years to support her research into pancreatic ductal adenocarcinoma.
In a phase II clinical trial, a research team led by Nilofer Azad, professor of oncology and co-leader of the Kimmel Cancer Center’s Cancer Genetics and Epigenetics Program, and Marina Baretti, the Jiasheng Chair in Hepato-Biliary Cancer at the Kimmel Cancer Center, tested the safety and efficacy of the combination of two drugs: an immunotherapy, nivolumab, and an epigenetic drug, entinostat—a histone deacetylase inhibitor.
